Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Is AxoGen Inc. (NASDAQ: AXGN) Still A Buy After A -8.27% Weekly Drop?
04:30pm, Saturday, 12'th Mar 2022 Marketing Sentinel
During the last session, AxoGen Inc. (NASDAQ:AXGN)’s traded shares were 0.49 million, with the beta value of the company hitting 0.76. At the end of the trading day, the stock’s price was $8.32, reflecting an intraday loss of -2.23% or -$0.19. The 52-week high for the AXGN share is $23.94, that puts it down -187.74 … Is AxoGen Inc. (NASDAQ: AXGN) Still A Buy After A -8.27% Weekly Drop? Read More »
Axogen Needs RECON More Than Ever To Recharge The Bull Case
10:50pm, Tuesday, 08'th Mar 2022 Seeking AlphaAxogen Needs RECON More Than Ever To Recharge The Bull Case
05:50pm, Tuesday, 08'th Mar 2022
Axogen reported disappointing fourth quarter results, with procedure volume down 8% on issues related to COVID-19 and hospital staffing.
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q4 2021 Results - Earnings Call Transcript
02:03am, Wednesday, 23'rd Feb 2022 Seeking Alpha
AxoGen (AXGN) Reports Q4 Loss, Tops Revenue Estimates
11:15pm, Tuesday, 22'nd Feb 2022 Zacks Investment Research
AxoGen (AXGN) delivered earnings and revenue surprises of 38.46% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Axogen, Inc. Reports 2021 Fourth Quarter and Full-Year Financial Results
09:34pm, Tuesday, 22'nd Feb 2022 GlobeNewswire Inc.
ALACHUA, Fla. and TAMPA, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q4 2021 Results - Earnings Call Transcript
09:03pm, Tuesday, 22'nd Feb 2022
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q4 2021 Results - Earnings Call Transcript
AxoGen (AXGN) Reports Q4 Loss, Tops Revenue Estimates
07:59pm, Tuesday, 22'nd Feb 2022
AxoGen (AXGN) delivered earnings and revenue surprises of 38.46% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
AxoGen Q4 2021 Earnings Preview (NASDAQ:AXGN)
10:35pm, Monday, 21'st Feb 2022 Seeking Alpha
AxoGen (NASDAQ:AXGN) is scheduled to announce Q4 earnings results on Tuesday, February 22nd, after market close.The consensus EPS Estimate is -$0.13 (-62.5% Y/Y) and the consensus
Earnings Preview: AxoGen (AXGN) Q4 Earnings Expected to Decline
08:01pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: AxoGen (AXGN) Q4 Earnings Expected to Decline
04:10pm, Tuesday, 15'th Feb 2022
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axogen to Participate at Upcoming Investor Conferences
12:00pm, Thursday, 03'rd Feb 2022 GlobeNewswire Inc.
ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
Axogen to Participate at Upcoming Investor Conferences
07:00am, Thursday, 03'rd Feb 2022
ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022
12:00pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022
07:00am, Wednesday, 02'nd Feb 2022
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
